Director of Product Strategy and Management, Ultivue
Gourab is currently leading Ultivue’s Product Strategy and Management. He is a Biomedical Researcher with extensive experience in assay/technology development for molecular pathology and diagnostics. Over the last seven years, he and his team have created groundbreaking advances in biomarker detection technologies to support translational researchers with an end-to-end solution that provides clinical-grade biological insights to validate clinical trial hypotheses.
He led key research efforts towards development and launch of Ultivue’s foundational InSituPlex® (ISP) assays and expanded its applications with OmniVUE™ and U-VUE® biomarker panels. Currently, he is leading strategic initiatives across Ultivue’s portfolios by combining its core technologies (InSituPlex® and STARVUE™) towards having a transformative impact on precision medicine.
Gourab holds a Ph.D. in Bioengineering from University of Washington Seattle where he developed novel DNA-based nanosystems that can perform molecular computation inside living cells.
This white paper highlights the value of an integrated ISP-in situ hybridization (ISH) workflow for co-detection of protein and RNA targets on a single FFPE tissue section.
Möchten Sie, dass wir Ihren Text veröffentlichen?
Wir sind stets auf der Suche nach weiteren interessanten Autoren, die wir hier vorstellen möchten. Reichen Sie Ihren Beitrag ein und wir melden uns bei Ihnen!
